SCHEMBL8480001

SCHEMBL8480001

CCCCc1c(N2CCCCC2)cc(NC(=O)c2ccccc2Oc2ccccc2)c2c1C(C(=O)NCC(F)(F)F)c1ccccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ BRPF1 P55201 6/20 0.36
▸ BRD4 O60885 4/20 0.36
▸ BRD1 O95696 3/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ BRD9 Q9H8M2 2/20 0.35
▸ BRPF3 Q9ULD4 2/20 0.35
▸ TAF1 P21675 1/20 0.35
▸ CECR2 Q9BXF3 1/20 0.35
▸ BRD7 Q9NPI1 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8479944 0.98 MAPT (0.37) MAPTTP53MEN1KMT2ABRPF1
SCHEMBL8482589 0.93 RXFP1 (0.34) MAPTTP53MEN1KMT2ABRPF1
SCHEMBL8483454 0.89 MEN1 (0.35) MAPTTP53MEN1KMT2AKDM4E
SCHEMBL8523535 0.89 KMT2A (0.40) MAPTTP53MEN1KMT2ABRPF1
SCHEMBL8667926 0.87 MEN1 (0.37) MAPTTP53MEN1KMT2ARXFP1
Hydrochloric Acid SCHEMBL8663917 0.86 MEN1 (0.36) MAPTTP53MEN1KMT2ARXFP1
SCHEMBL8667142 0.86 MAPT (0.36) MAPTTP53MEN1KMT2ABRPF1
SCHEMBL8573190 0.86 MEN1 (0.35) MAPTMEN1KMT2ARXFP1RAB9A
SCHEMBL8653102 0.86 HCRTR1 (0.35) MAPTTP53MEN1KMT2ABRPF1
SCHEMBL8504394 0.86 MEN1 (0.37) MAPTTP53MEN1KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
US-H1729-H Method for preparing compounds employing solid phase synthesis and novel linker-resin BRISTOL-MYERS SQUIBB COMPANY (US) 1998-05-05 — — US disclosed
Send feedback